Khaitan & Co and JSA advised on Arboreal Bioinnovations’ INR 230 Crore Series A funding round.
Arboreal Bioinnovations, a specialty food and nutraceutical ingredients technology company, raised INR 230 crore in its Series A funding round led by EAAA Alternatives and Omnivore Agritech & Climate Sustainability Fund 3, with continued participation from existing investor Rainmatter by Zerodha.
The transaction also included secondary acquisitions of shares from certain existing shareholders by Rainmatter, EAAA Alternatives and Omnivore.
Khaitan & Co advised Arboreal Bioinnovations on the ₹230 crore Series A funding round.
The core team comprised Hardik Bhatia, Nishant Mathews, Rhythm Chopra and Insaf Ahamad.
JSA Advocates & Solicitors advised EAAA Alternatives and Omnivore on their investment in Arboreal, including the primary subscription and the associated secondary acquisitions from existing shareholders.
The transaction team was led by Partners Siddharth Mody and Anurag Shrivastav, supported by Senior Associate Esha Himadri and Associates Gavin Pereira and Damini Chouhan. The due diligence team comprised Partner Anurag Shrivastav, Senior Associate Tanmayee Sahoo, and Associates Gavin Pereira and Prakhar Jain.
The deal reporting on this platform is based on the information received from law firms, and therefore, some details may be missing/incomplete. If your firm has not been credited for this deal, write to us at chanchal.makhija@thegreymatter.co.in mentioning your firm’s name, lawyers involved (including designation) and client represented.